Lazard Asset Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.09M | Sell |
|
|||||
|
2025
Q2 | $1.43M | Sell |
|
|||||
|
2025
Q1 | $3.75M | Buy |
|
|||||
|
2024
Q4 | $818K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $31K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $63K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $250K | Sell |
|
|||||
|
2021
Q4 | $236K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $191K | Sell |
|
|||||
|
2020
Q1 | $139K | Buy |
|
|||||
|
2019
Q4 | $37K | Sell |
|
|||||
|
2019
Q3 | $139K | Buy |
|